These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15067860)

  • 1. Parents' attitude towards the second dose of measles, mumps and rubella vaccine: a case-control study.
    Petrovic M; Roberts RJ; Ramsay M; Charlett A
    Commun Dis Public Health; 2003 Dec; 6(4):325-9. PubMed ID: 15067860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The knowledge about measles, mumps and rubella among parents in the county of Roskilde].
    Hansen LF
    Ugeskr Laeger; 2002 Dec; 164(49):5748-52. PubMed ID: 12523211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the media on the decision of parents in South Wales to accept measles-mumps-rubella (MMR) immunization.
    Walsh S; Thomas DR; Mason BW; Evans MR
    Epidemiol Infect; 2015 Feb; 143(3):550-60. PubMed ID: 25600667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey.
    Brown K; Fraser G; Ramsay M; Shanley R; Cowley N; van Wijgerden J; Toff P; Falconer M; Hudson M; Green J; Kroll JS; Vincent C; Sevdalis N
    PLoS One; 2011; 6(5):e19381. PubMed ID: 21602931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [So dangerous are not measles, mumps and rubella...A qualitative survey of causes of MMR vaccination refusal in the county of Vejle].
    Gerdes J; Thorsen T
    Ugeskr Laeger; 2006 Aug; 168(33):2670-4. PubMed ID: 16942688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis.
    Brown KF; Long SJ; Ramsay M; Hudson MJ; Green J; Vincent CA; Kroll JS; Fraser G; Sevdalis N
    Vaccine; 2012 Feb; 30(10):1855-64. PubMed ID: 22230590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timely MMR vaccination in infancy: influence of attitudes and medical advice on the willingness to vaccinate.
    Schönberger K; Ludwig MS; Wildner M; Kalies H
    Klin Padiatr; 2012 Nov; 224(7):437-42. PubMed ID: 22821294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of measles containing vaccines in the measles, mumps, and rubella second dose catch-up programme in Wales.
    Thomas DR; King J; Evans MR; Salmon RL
    Commun Dis Public Health; 1998 Mar; 1(1):44-7. PubMed ID: 9718839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles.
    Morgan OW; Meltzer M; Muir D; Hogan H; Seng C; Hill J; Beckford J
    Commun Dis Public Health; 2003 Dec; 6(4):330-3. PubMed ID: 15067861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors].
    Rotily M; Guagliardo V; Fontaine D; Garros B; Mayer C; Arrighi J; Woronoff AS; Ledesert B; Lepec R; Chabaud F; Janvrin MP; Baudier F
    Rev Epidemiol Sante Publique; 2001 Sep; 49(4):331-41. PubMed ID: 11567200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument.
    Brown KF; Shanley R; Cowley NA; van Wijgerden J; Toff P; Falconer M; Ramsay M; Hudson MJ; Green J; Vincent CA; Kroll JS; Fraser G; Sevdalis N
    Vaccine; 2011 Feb; 29(8):1700-9. PubMed ID: 21185850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children.
    He H; Chen E; Chen H; Wang Z; Li Q; Yan R; Guo J; Zhou Y; Pan J; Xie S
    Vaccine; 2014 Jun; 32(31):4001-5. PubMed ID: 24837773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.